Cita APA

L., E., C., S., P., V., M.J., M., C., C., C., B., . . . F., D. (2023). Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.

Citación estilo Chicago

L., Exposito, Sánchez-Piedra C., Vela-Casasempere P., Moreno-Ramos M.J., Campos C., Bohorquez C., Manero J., Mª Dolores Ruiz Montesino, y Díaz-González F. Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy Versus Combination Therapy in Patients With Chronic Inflammatory Arthritis. 2023.

Cita MLA

L., Exposito, et al. Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy Versus Combination Therapy in Patients With Chronic Inflammatory Arthritis. 2023.